Invasive fungal wound infections (IFIs) are a recognized threat for personnel who sustain combat-related blast trauma in Afghanistan. Blast trauma, particularly when dismounted, has wounds contaminated with organic debris and potential for mold infection. Trauma-associated IFI is characterized by recurrent wound necrosis on serial debridement with histologic evidence of invasive molds and/or fungal culture growth. Wounds with mold growth but lacking corresponding recurrent necrosis present a clinical dilemma of whether to initiate antifungal treatment. Our objective was to assess the clinical significance of fungal culture growth without recurrent wound necrosis.
W
hile advances in body armor and combat casualty care have led to improved survival rates from complex injuries during recent military conflicts, 1Y3 new complications during wound stabilization, treatment, and reconstruction are being observed. In particular, invasive fungal wound infections (IFIs) have emerged in association with dismounted (foot patrol) blast injuries in southern Afghanistan. 2,4Y6 This environment is thought to harbor molds capable of inoculating wounds following detonation of improvised explosive devices. 4, 5 Wound contamination, a known factor related to IFI development among civilian trauma cases, allows for mold colonization or fungal invasion of viable tissue surrounding wound sites. 2, 5, 7, 8 Although not all wound contamination leads to IFI, the high mortality associated with the disease makes it a legitimate concern. A review of 929 cases of mucormycosis (primarily sinus, pulmonary, and cutaneous) reported a survival rate of 57% with surgery alone, 62% with antifungal treatment, 70% when antifungal therapy was combined with surgery, and 3% when no treatment was initiated. 9 In addition, following the tornado disaster in Joplin, Missouri, 13 patients developed IFI, of whom 5 (38%) died despite antifungal and surgical treatment.
risks of antifungal therapy (e.g., drug interactions, nephrotoxicity, and hepatotoxicity) 10 are justified. When the diagnosis is less clear, the hazards of antifungal use warrant further scrutiny. This is often the case when wound cultures yield fungi, but histopathologic evidence of infection and/or recurrent wound necrosis consistent with IFI are lacking.
With the rising awareness that early recognition and treatment were critical to effectively manage IFI, our clinicians were faced with a dilemma when wounds grew mold but lacked the IFI hallmark of recurrent necrosis despite serial debridement. Consequently, there was uncertainty about the utility of antifungal therapy in these scenarios. Therefore, we evaluated the clinical relevance of fungal growth in association with wound appearance with respect to outcome by comparing data from patients with and without recurrent wound necrosis to provide clinicians with information to aid decision making regarding the initiation of antifungal therapy.
PATIENTS AND METHODS

Study Population
Data were collected from US military personnel who were injured in combat in Afghanistan (June 2009 through August 2011), medically evacuated to Landstuhl Regional Medical Center (LRMC) in Germany for initial care, and then admitted to a participating US military treatment facility (MTFs): Walter Reed Army Medical Center in Washington, District of Columbia; National Naval Medical Center in Bethesda, Maryland; and San Antonio Military Medical Center in San Antonio, Texas. The overarching project for this analysis is the ongoing 5-year observational cohort study of short-and long-term infectious complications following deployment-related traumatic injuries during recent military conflicts, the US Department of Defense (DoD)Y Department of Veterans Affairs, Trauma Infectious Disease Outcomes Study (TIDOS). 1 As previously described, 4, 11, 12 a subset of the combat casualty population with suspected IFI was identified by reviewing the TIDOS database for wound cultures with fungal growth and/or fungal elements on histology (i.e., viable tissue invasion with/without fungal hyphae angioinvasion) in association with traumatic wounds. As part of the process to identify patients for inclusion, histopathology (reviewed by two surgical pathologists) and clinical mycology reports were evaluated. Moreover, records from the infectious disease and trauma surgery services were examined.
Clinical Definitions and Data Collection
Based on histopathologic and/or culture evidence of mold, patients were identified for inclusion in the study population and then stratified by clinical wound appearance after two initial debridements (with/without recurrent necrosis). The DoD Trauma Registry 3 was used to obtain trauma and inpatient data for the subjects included in the subset. Mycologic data were collected using the supplemental TIDOS infectious disease module. Operative notes from the US MTFs were retrospectively reviewed for evidence of recurrent necrosis on successive debridements. The study was approved by the Infectious Diseases Institutional Review Board of the Uniformed Services University of the Health Sciences (Bethesda, MD).
Statistical Analysis
A previous analysis compared patients with histopathologic evidence of mold with those with culture evidence of mold (all with recurrent wound necrosis) and did not find many significant differences in clinical characteristics or outcomes; therefore, these two groups were combined for the current analysis and were compared with patients with culture evidence of mold without recurrent wound necrosis. 13 Categorical variables were compared using W 2 or Fisher's exact testing. When appropriate, exact nonparametric testing (t test or Wilcoxon rank-sum test) for continuous variables was conducted. Statistical analysis was performed using SAS version 9.3 (SAS, Cary, NC) and R version 2.13.2 (R Project for Statistical Computing, Vienna, Austria), and significance was defined as p G 0.05.
RESULTS
Patient Demographics and Injury Patterns
An examination of data from 1,133 combat casualties identified 96 patients with fungal growth from wounds and/or fungal elements on histopathology; of whom there were 77 patients (6.8% of 1,133) with recurrent wound necrosis following at least two successive surgical debridements. The remaining 19 patients had fungal culture growth without associated fungal elements on histopathology and did not have recurrent wound necrosis, representing a convenience sample for comparison based on available data. All subjects were male, with a median age of 23 years, and were predominantly Marines. There was no significant difference (p = 1.00) regarding mechanism of injury between the groups, with approximately 95% of injuries resulting from blasts and more than 89% occurring while dismounted. Injury pattern was also comparable with 38% and 53% of the patients with and without recurrent wound necrosis, respectively, involving traumatic above-the-knee amputations (p = 0.30).
Clinical Characteristics
An examination of shock indices and clinical characteristics (Table 1 ) assessed at combat support hospitals, LRMC, and the US MTFs largely reported similar results between the groups. One difference was that on presentation to combat support hospitals, patients with wounds that were eventually complicated by recurrent necrosis were significantly more hypotensive (median systolic blood pressure, 99 vs. 130; p = 0.02) and acidotic (median pH, 7.2 vs. 7.3; p = 0.03) compared with the patients without recurrent necrosis. Because of severe hemorrhage at the time of injury, large-volume blood product transfusions were required during the initial 24 hours of care with no statistical difference between the patient groups. On admission to LRMC, both groups had a median Injury Severity Score (ISS) of 21; however, the overall median Sequential Organ Failure Assessment (SOFA) score was higher, although not statistically significant, for the patients who developed recurrently necrotic wounds ( Table 1) . Indicators of an infection (elevated white blood cell count and temperature) were comparable between the groups at LRMC (approximately 2 days of hospitalization) but were statistically increased among patients with recurrent necrosis following transition to the US MTFs during the first 2 weeks of hospitalization (p G 0.05).
Wound Mycology
By definition, all of the patients in the group without recurrent necrosis had fungal growth, whereas only 78% of the patients with recurrent wound necrosis grew mold (remainder had fungal elements seen on histopathology). The proportion of Mucorales growth was comparable between the groups; however, patients without recurrent necrosis had significantly more growth of Aspergillus at LRMC (p = 0.03; Table 2 ).
Invasive Fungal Infection Management
Only 16% of the subjects without recurrent necrosis were prescribed antifungal therapy compared with 84% of the patients with recurrently necrotic wounds (p G 0.01; Table 3 ). Patients without recurrent necrosis who were prescribed amphotericin B (liposomal) also received it for a significantly shorter duration compared with subjects with recurrent wound necrosis (p = 0.01).
In addition, the number of operating room visits for surgical debridements was increased (p = 0.02) among patients with recurrently necrotic wounds.
Clinical Outcomes
Patients with recurrent wound necrosis had a significant increase in the total time spent in the intensive care unit (ICU, p G 0.01, Table 3 ). Moreover, there were a greater number of patients who sustained high-level amputations (i.e., total hip disarticulation or hemipelvectomy) within the group with recurrently necrotic wounds, but the increase was not statistically significant. Although there were no deaths within the group without recurrent wound necrosis and six (7.8%) among the patients with recurrently necrotic wounds, the overall difference in crude mortality between the groups was not statistically significant.
DISCUSSION
Although not as common as bacterial infections, IFIs have significant impact on the morbidity and mortality of wounded military personnel. 4 ,11Y14 Because of the progressive and serious nature of trauma-related IFIs, there is general agreement that early diagnosis, aggressive serial debridement, minimization of immunosuppression, and treatment with systemic antifungal therapy constitute the soundest strategy for the management of this disease. 4,7,8,14Y16 The clinical significance of cultures growing mold without the clinical stigmata of IFIs presents challenges in determining the appropriate management. While we recognize the critical need for early empirical antifungal therapy to properly manage IFIs, treatment should be based on clinical indicators of the disease to avoid the unnecessary use of intravenous antifungals because they may result in nephrotoxicity and hepatotoxicity. Consequently, the aim of this study was to compare injury patterns, baseline clinical characteristics, clinical mycology, treatment modalities, and outcomes among patients with confirmed IFIs 4, 11, 12 with those with wound cultures growing mold without associated recurrent tissue necrosis.
The groups were not significantly different regarding mechanisms and patterns of injury, along with most clinical characteristics. Therefore, it was reasonable to assume that the patients in both groups were at risk for developing IFIs, particularly since dismounted blast injuries and above-the-knee amputations are recognized risk factors for the disease. 12 Although the clinical relevance is not definitively known, patients who developed recurrent wound necrosis were statistically more hypotensive and acidotic on initial presentation, suggesting wounds complicated by more severe exsanguinating hemorrhage. Once the patients were admitted to US MTFs following their short hospitalization at LRMC, clinical courses diverged as patients with recurrently necrotic wounds presented with indicators consistent with an infection (i.e., more febrile and leukocytosis).
In general, patients with recurrent wound necrosis did have significantly longer stay in the ICU and a greater number of operating room visits. While no deaths were reported in the group without recurrent necrosis, there were six among the cases with recurrently necrotic wounds. This may be in part caused by the limitation of having a relatively small retrospective comparison group (19 patients without recurrent wound necrosis), which was a convenience sample.
The predominant fungal isolates identified among both groups were Mucorales and Aspergillus. While Aspergillus is known to be associated with contamination, 14, 17 Mucorales is not. 18 Of the group without recurrent wound necrosis, 11% grew Mucorales, and all were treated with antifungal medications; however, the medications were stopped typically by 5 days. The use of antifungal agents (notably liposomal amphotericin B) in this situation may reflect the practice of many clinicians placing a higher relevance on a wound culture yielding Mucorales. In our opinion, this practice is justified based on the known potential of this pathogen to cause locally invasive IFIs with high morbidity and mortality. While not statistically significant, patients with Mucorales growth from a wound culture in our analysis were much more likely to have recurrent wound necrosis.
Overall, our analysis indicates that clinicians from LRMC and the participating US MTFs demonstrated antimicrobial stewardship based on the fact that very few subjects (three patients, 16%) without recurrent wound necrosis received antifungal therapy and, if they did, it was discontinued after short durations. This group of patients was not negatively impacted because of the lack of antifungal therapy, as evidenced by reduced length of ICU stay, fewer high-level amputations, and zero mortality, suggesting that the patients did not have an IFI.
In summary, our data corroborate the supposition that the presence of fungal growth without recurrent necrosis neither supports an IFI diagnosis nor constitutes a need for antifungal therapy. To optimize the care of trauma patients, a clinician must consider the whole clinical picture (e.g., injury mechanism/pattern that are recognized risk factors, 12 recurrent wound necrosis, extent of leukocytosis, and temperature elevation) supplemented by tissue histopathology to conclude that fungal growth in wound tissue is the result of colonization rather than IFI.
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